Oxygen is probably the drug that we give the most but possibly has the least governance over.  More has got to be good except in those at high risk of type II respiratory failure right?? Well as we know the evidence base has swung to challenge that idea in recent years and the new BTS guidelines for Oxygen use in Healthcare and Emergency Settings has just been published with a few things that are worth reviewing since the original publication in 2008. No apologies that this may be predominantly old ground here, this is an area we're all involved with day in and day out that is simple to correct and affects mortality

Historically oxygen has been given without prescription;

• 42% of patients in the 2015 BTS audit had no accompanying prescription
• When it is prescribed this doesn't always correlate with delivery
• 1/3 of patients were outside of target SpO2 range (10% below & 22% above)

If nothing else is taken from this document then reinforcement of the fact that we need to keep oxygen saturations normal/near normal for all patients, except groups at risk of type II respiratory failure

Prescribe and delivery oxygen by target oxygen saturations

What is normal?

• Normal Oxygen saturations for healthy young adults is approximately 96-98%, there is minor decrease with increasing age.
• Healthy subjects desaturate to 90% SpO2 during night time; be cautious interpreting a single oximetry reading from a sleeping patient, short duration overnight dips are normal

Will mental status give me an early indication of hypoxaemia?

• No, impaired mental function at a mean value of SaO2 64%, no evidence above SaO2 84%
• Loss of consciousness at a mean SaO2 56%

Aims of oxygen therapy

• Correct potentially harmful hypoxia
• Alleviate breathlessness only in those hypoxic

Why the fuss about hyperoxia?

Hyperoxia has been shown to be associated with

Which patients are at risk of CO2 retention and acidosis if given high dose oxygen?

• Chronic hypoxic lung disease
  • COPD/CF/Bronchiectasis
• Chest wall disease
  • Kyphoscoliosis
  • Thoracoplasty
• Neuromuscular disease
• Morbid obesity with hypo ventilatory syndrome

What is the oxygen target?

Oxygen titrated to an SpO2 of 94-98%

Except in those at risk of hypercapnia respiratory failure, then 88-92%(or specific SpO2 on patient's alert card)

What about in Palliative Care?

Most breathlessness in cancer patients is caused by airflow obstruction, infections or pleural effusions and in these cases the issues need to be addressed. Oxygen does relieve breathlessness in hyperaemic cancer patients but not if SpO2 >90%. Midazolam and morphine also relieve breathlessness and are more likely to be effective.

Delivery Devices

• Reservior masks can deliver O2 concentrations between 60-80%
• Nasal cannualae at 1-6L/min can deliver 24-50%
• Venturi masks allow accurate delivery of O2
• If tachypnoeic over 30 breaths per minute an increase over the marked flow rate should be delivered, note this won't increase the FiO2!

Equivalent doses of O2

24% venturi = 1L O2

28 % venturi = 2L O2

35% venturi = 4L O2

40% venturi = nasal/facemask 5-6LO2

60% venturi = 7-10L simple face mask

Approach to oxygen delivery

Firstly determine if at risk of type II respiratory failure

If not;

• SpO2 < 94%, deliver oxygen
• Perform an ABG
  • If high PCO2 consider invasive ventilation, in the interim aim SpO2 94-98%
  • If PCO2 normal or low aim SpO2 94-98% and repeat ABG in 30-60 minutes

If at risk of type II respiratory failure

• Obtain ABG if hypoxic or already on oxygen
  • If a respiratory acidosis consider NIV, address medical condition and senior review. Treat with the lowest FiO2 via venturi or nasal specs to maintain an SpO2 88-92%
  • If hypercapnia but not acidotic, titrate the lowest FiO2 via venturi or nasal specs to maintain an SpO2 88-92%. Repeat ABG after change of treatment/deterioration. Consider reducing FiO2 if PO2 on ABG >8kPa
  • If PCO2 < 6 (normal or low) aim to keep SpO2 94-98% and repeat the ABG in 30-60 minutes

Points specific to prehospital oxygen use

• A sudden reduction in 3% of SpO2 within the target range should prompt a fuller assessment of the patient
• Pulse oximetry must be available in all locations in which oxygen is being used
• Some patients over the age of 70 when clinically stable may have SpO2 between 92-94%, these patients don't require O2 therapy unless the SpO2 falls below the level that is known to be normal for that individual
• Patients with COPD should initially be given oxygen via 24% venturi at 2-4L/min or 28% mask at a flow rate 4L/min, or nasal cannulae at 1-2L/min aiming for 88-92%
• Patients over 50 years of age and long term smoker with a history of SOB on exertion and no other cause for their breathlessness should be treated as having COPD.
• Limit O2 driven nebs, if no air driven nebs available, to 6 minutes in duration in patients known to have COPD

In summary....

So the bottom line? Well just like Goldielock's porridge, with oxygen we don't want too little, we don't want too much but we want just the right amount!

There is no doubt that hypoxia kills but beware that too much of anything is bad for you and in the same way we need to be vigilant to targeting oxygen delivery to our patients target SpO2

References

BTS Guideline for oxygen use in healthcare and emergency settings

How many patients are admitted from your ED with suspected cardiac chest pain? What strategy of testing do you employ to rule out acute myocardial infarction? When and why do you send troponins in this process?

In this podcast Ed Carlton, Emergency Medicine Consultant at North Bristol Hospital and Troponin Researcher, talks to us about troponin rule out strategies, recent publications on the topics, where the future of troponin research is heading and most importantly what this all means for our practice.

Our previous podcast on troponins acts as a good introduction to this episode. Have a listen to both and we'd love to hear your comments at the bottom of the page and we hope you found this as useful as we did!

Enjoy

Simon

References

Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin TMeasurement Below the Limit of Detection: A Collaborative Meta-analysis. Pickering JW. Ann Intern Med. 2017 

Effect of Using the HEART Score in Patients With Chest Pain in the Emergency Department: A Stepped-Wedge, Cluster Randomized Trial. Poldervaart JM. Ann Intern Med. 2017

This month we've got a good variety of topics.

We look at an recent systematic review and meta analysis on the prognostic value of echo in life support, an update from Blyth's paper in 2012. We review a paper looking at testing gin patients presenting to the emergency department in SVT. Finally we cover a paper looking at different methods employed when running an Emergency Department.

As always make sure you go and have a read of the papers yourselves and come up with your own conclusions, we'd love to hear your feedback.

Enjoy!

Simon & Rob

References & Further Reading

Accuracy of point-of-care focused echocardiography in predicting outcome of resuscitation in cardiac arrest patients: A systematic review and meta-analysis. Tsou PY. Resuscitation. 2017

Usefulness of laboratory and radiological investigations in the management of supraventricular tachycardia. Ashok A. Emerg Med Australas.2017

What do emergency physicians in charge do? A qualitative observational study. Hosking I. Emerg Med J. 2017